Results 241 to 250 of about 51,741 (305)

Signatures of Trained Immunity Following mRNA Vaccination: Differences Between mRNA-1273 and BNT162b2. [PDF]

open access: yesJ Clin Immunol
Kunc M   +6 more
europepmc   +1 more source

Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents

open access: gold
Qiong Wu   +26 more
openalex   +1 more source

Supplementary Material for: Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients

open access: gold, 2022
Yael Einbinder   +11 more
openalex   +1 more source

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

open access: yesThe Lancet, 2021
A. Munro   +308 more
semanticscholar   +1 more source

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa

open access: yesNew England Journal of Medicine, 2021
Shirley-anne Collie   +4 more
semanticscholar   +1 more source

Temporal dynamics of SARS-CoV-2 antibodies and IgG subclasses following multiple doses and diverse COVID-19 vaccine combinations. [PDF]

open access: yesFront Immunol
Meyer J   +8 more
europepmc   +1 more source

Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature. [PDF]

open access: yesJ Med Case Rep
Chandrasekaran S   +7 more
europepmc   +1 more source

Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose [PDF]

open access: yes
Atzori, Luigi   +14 more
core   +1 more source

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

open access: green, 2022
Paulina Kapłonek   +19 more
openalex   +2 more sources

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

open access: yesThe Lancet, 2021
V. Hall   +347 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy